Brucella carbonic anhydrases: New targets for designing anti-infective agents

Current Pharmaceutical Design

Volumn 16, Issue 29, 2010, Pages 3310-3316

  Winum, Jean Yves ^a   Köhler, Stephan ^b   Supuran, Claudiu T ^c  

^a INSTITUT CHARLES GERHARDT   (France)

^b University of Montpellier I and II   (France)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

carbonic anhydrase; Brucella suis; Brucellosis; Inhibition; Sulfonamide

Indexed keywords

ACETAZOLAMIDE; ANTIINFECTIVE AGENT; BENZOLAMIDE; BRINZOLAMIDE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CELECOXIB; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; INDISULAM; METALLOPROTEIN; METHAZOLAMIDE; SULPIRIDE; TOPIRAMATE; VALDECOXIB; ZONISAMIDE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOTRANSFORMATION; BRUCELLA; CULTURE MEDIUM; DRUG DESIGN; DRUG TARGETING; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; BRUCELLA; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MOLECULAR TARGETED THERAPY; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; SULFONIC ACIDS;

EID: 78649821766     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210793429850     Document Type: Article

References (26)

1. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006; 6: 91-9.
2. Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a reemerging zoonosis. Vet Microbiol 2010; 140: 392-8.
3. Franco MP, Mulder M, Gilman RH, Smits HL. Human Brucellosis. Lancet Infect Dis 2007; 7: 775-86.
4. Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci 2006; 63: 2229-36.
5. Perkins SD, Smither SJ, Atkins HS. Towards a Brucella vaccine for humans. FEMS Microbiol Rev 2010; 34: 379-94.
6. DelVecchio VG, Kapatral V, Redkar RJ, et al. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc Natl Acad Sci USA 2002; 99: 443-8.
7. Paulsen IT, Seshadri R, Nelson KE, et al. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc Natl Acad Sci USA 2002; 99: 13148-53.
8. Halling SM, Peterson-Burch BD, Bricker BJ, et al. Completion of the genome sequence of Brucella abortus and comparison to the highly similar genomes of Brucella melitensis and Brucella suis. J Bacteriol 2005; 187: 2715-26.
9. Köhler S, Foulongne V, Ouahrani-Bettache S, et al. The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell. Proc Natl Acad Sci USA 2002; 99: 15711-6.
10. Winum JY, Köhler S, Scozzafava A, Montero JL, Supuran CT. Targeting bacterial metalloenzymes: A new strategy for the development of anti-infective agents. Anti-Infect Agents Med Chem 2008; 7: 169-79.
11. Joseph P, Turtaut F, Köhler S, Winum JY. Inhibitors of histidinol dehydrogenases as antibacterial agents. In: Supuran CT, Winum JY. Eds. Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Hoboken: Wiley 2009; pp. 937-50.
12. Abdo MR, Joseph P, Boigegrain RA, et al. Brucella suis histidinol dehydrogenase: synthesis and inhibition studies of a series of substituted benzylic ketones derived from histidine. Bioorg Med Chem 2007; 15: 4427-33.
13. Joseph P, Abdo MR, Boigegrain RA, Montero JL, Winum JY, Köhler S. Targeting of the Brucella suis virulence factor histidinol dehydrogenase by histidinol analogues results in inhibition of intramacrophagic multiplication of the pathogen. Antimicrob Agents Chemother 2007; 51: 3752-5.
14. Nishimori I, Minakuchi T, Morimoto K, et al. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alphacarbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J Med Chem 2006; 49: 2117-26.
15. Nishimori I, Onishi S, Takeuchi H, Supuran CT. The α and β classes carbonic anhydrases from Helicobacter pylori as novel drug targets. Curr Pharm Des 2008; 14: 622-30.
16. Minakuchi T, Nishimori I, Vullo D, Scozzafava A, Supuran CT. Molecular cloning, characterization and inhibition studies of the Rv1284 β-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. J Med Chem 2009; 52: 2226-32.
17. Nishimori I, Minakuchi T, Vullo D, Scozzafava A, Innocenti A, Supuran CT. Carbonic anhydrase inhibitors. cloning, characterization, and inhibition studies of a new β-carbonic anhydrase from Mycobacterium tuberculosis. J Med Chem 2009; 52: 3116-20.
18. Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7: 168-81.
19. Nishimori I, Minakuchi T, Kohsaki T, et al. Carbonic anhydrase inhibitors. The β-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. Bioorg Med Chem Lett 2007; 17: 3585-94.
20. Joseph P, Turtaut F, Ouahrani-Bettache S, et al. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis. J Med Chem 2010; 53: 2277-85.
21. Joseph P, Ouahrani-Bettache S, Montero JL, et al. A new brucella suis carbonic anhydrase, bsCA II: inhibition of bsCA I and bsCA II by sulfonamides and sulfamates impairs pathogen growth. Bioorg Med Chem 2010; submitted.
22. Vullo D, Nishimori I, Scozzafava A, Köhler S, Winum JY, Supuran CT. Inhibition studies of a beta-carbonic anhydrase from Brucella suis with a series of water soluble glycosyl sulfanilamides. Bioorg Med Chem Lett 2010; 20: 2178-82.
23. Dozot M, Boigegrain RA, Delrue RM, et al. The stringent response mediator Rsh is required for Brucella melitensis and Brucella suis virulence, and for expression of the type IV secretion system virB. Cell Microbiol 2006; 8: 1791-802.
24. Supuran CT. Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr Pharm Des 2008; 14(7): 641-648.
25. Supuran CT. Carbonic anhydrases--an overview. Curr Pharm Des 2008; 14(7): 603-614.
26. Winum JY, Scozzafava A, Montero JL, Supuran CT. Design of zinc binding functions for carbonic anhydrase inhibitors. Curr Pharm Des 2008; 14(7): 615-621.